Stanley Koontz, MD
Emergency Medicine · New Bern, NCNPI 1780662411
Payments from drug & device makers
Across 48 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$120
- Novo Nordisk$62
- Boehringer Ingelheim$58
- Johnson & Johnson$53
- Lilly USA, LLC$51
- Amarin Pharma, Inc.$49
- plus $353 from 15 others
What the payments were for
- Food & beverage$747100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $120 |
| Novo Nordisk | 4 | $62 |
| Boehringer Ingelheim | 4 | $58 |
| Johnson & Johnson | 4 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Amarin Pharma, Inc. | 3 | $49 |
| AbbVie(2 entities) | 2 | $45 |
| CSL Behring | 3 | $43 |
| Daiichi Sankyo Inc. | 3 | $39 |
| Eisai Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $24 |
| Antares Pharma, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Pfizer | 1 | $14 |
| Novartis | 1 | $14 |
| Merck | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$747 in reported general payments places this provider in the 90th percentile of 1,657 emergency medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 25 | $708 |
| Ondansetron OdtOndansetron | 35 | $427 |
| Pantoprazole Sodium | 14 | $402 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $312 |
| Methylprednisolone | 31 | $242 |
| Valsartan | 25 | $237 |
| Doxycycline Hyclate | 23 | $232 |
| Cephalexin | 19 | $197 |
| Famotidine | 15 | $190 |
| Prednisone | 51 | $174 |
| Losartan Potassium | 15 | $85 |
| Gabapentin | 13 | $76 |
| Azithromycin | 16 | $64 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $53 |
| Meloxicam | 18 | $34 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in New Bern
- Richard MontgomeryWinston-Salem$4.2M
- Simon MahlerWinston Salem$2.8M
- Judith BorgerFayetteville$2.3M
- Jason BischofChapel Hill$1.2M
- Heather LloydSylva$912K
- Alexander LimkakengDurham$860K
- Michael RunyonCharlotte$755K
- Gregory TarletonWinston-Salem$553K
- Boyd WashingtonCharlotte$369K
- Rahul PatelMorrisville$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.